Literature DB >> 28731897

Marginal Bone Loss Around Early-Loaded SLA and SLActive Implants: Radiological Follow-Up Evaluation Up to 6.5 Years.

Işil Damla Şener-Yamaner1, Gökhan Yamaner, Atilla Sertgöz, Cenk Fatih Çanakçi, Mutlu Özcan.   

Abstract

PURPOSE: The aim of this study was to compare marginal bone loss around early-loaded SLA and SLActive tissue-level implants (Straumann Dental Implants; Institut Straumann AG, Basel, Switzerland) after a mean of 81-month follow-up period.
MATERIAL AND METHODS: One hundred seven SLA and 68 SLActive implants were placed in 55 patients and loaded with final restoration after 8 and 3 weeks of healing time, respectively. Marginal bone loss around implants was determined radiographically at initial and after a mean observation time ranging between 20 and 81 months. The effect of location (mandible vs maxilla), smoking habit, sex, implant length and diameter, and the type of prosthesis on the marginal bone loss was evaluated.
RESULTS: The overall cumulative survival rate was 98.2% being 99% for SLA implants and 97% for SLActive implants. After 20-month follow-up period, mean marginal bone loss values for the SLA and SLActive implants were 0.24 and 0.17 mm, respectively. After 81 months, mean marginal bone loss for the SLA and SLActive implants reached 0.71 and 0.53 mm, respectively. Marginal bone loss was affected by the length and type of implant and patients' smoking habit after a mean observation time of 20 months. However, none of the parameters had any significant effect on the marginal bone loss after a follow-up period of 81 months.
CONCLUSION: With both SLA and SLActive implants, successful clinical results could be achieved up to 6.5 years of follow-up period.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28731897     DOI: 10.1097/ID.0000000000000625

Source DB:  PubMed          Journal:  Implant Dent        ISSN: 1056-6163            Impact factor:   2.454


  8 in total

1.  The osteoinduction of RGD and Mg ion functionalized bioactive zirconia coating.

Authors:  Zhengfei Huang; Zhifeng Wang; Chuanhua Li; Ning Zhou; Fei Liu; Jing Lan
Journal:  J Mater Sci Mater Med       Date:  2019-08-14       Impact factor: 3.896

2.  The response of soft tissue cells to Ti implants is modulated by blood-implant interactions.

Authors:  William A Lackington; Lada Fleyshman; Peter Schweizer; Yvonne Elbs-Glatz; Stefanie Guimond; Markus Rottmar
Journal:  Mater Today Bio       Date:  2022-05-22

Review 3.  Evaluation of osseintegration between traditional and modified hydrophilic titanium dental implants - Systematic analysis.

Authors:  Geeta Arya; Varun Kumar
Journal:  Natl J Maxillofac Surg       Date:  2020-12-16

4.  Stability of dental implants with sandblasted and acid-etched (SLA) and modified (SLActive) surfaces during the osseointegration period.

Authors:  Gulsum Sayin Ozel; Ozgur Inan; Asli Secilmis Acar; Gamze Alniacik Iyidogan; Dogan Dolanmaz; Gulsun Yildirim
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2021-12-05

Review 5.  How do peri-implant biologic parameters correspond with implant survival and peri-implantitis? A critical review.

Authors:  Ron Doornewaard; Wolfgang Jacquet; Jan Cosyn; Hugo De Bruyn
Journal:  Clin Oral Implants Res       Date:  2018-10       Impact factor: 5.977

6.  Permanent wettability of a novel, nanoengineered, clinically available, hyaluronan-coated dental implant.

Authors:  Marco Morra; Clara Cassinelli; Elisa Torre; Giorgio Iviglia
Journal:  Clin Exp Dent Res       Date:  2018-09-05

7.  Trabeculae microstructure parameters serve as effective predictors for marginal bone loss of dental implant in the mandible.

Authors:  Hengguo Zhang; Jie Shan; Ping Zhang; Xin Chen; Hongbing Jiang
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

8.  Greater Osseointegration Potential with Nanostructured Surfaces on TiZr: Accelerated vs. Real-Time Ageing.

Authors:  Andreas Stavropoulos; Rebecca Sandgren; Benjamin Bellon; Anton Sculean; Benjamin E Pippenger
Journal:  Materials (Basel)       Date:  2021-03-29       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.